Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by wildbird1on Apr 30, 2024 5:38pm

234 Views

Post# 36015977

One more reason the FDA badly need TLT-Ruvidar.

The BCG shortage was one good reason why the FDA badly need TLT-Ruvidar.

In this link...
https://dailymail.co.uk/news/fda/index.html

Now a chemotherapy drug shortage could be one more reason that the FDA badly need TLT-Ruvidar,chemotherapy(Cysplatin) is also used for bladder cancer patients.

One more reason why a Big Pharma will sign a nice $$deal for TLT-Ruvidar.

The $value of a TLT-Ruvidar keep increasing almost everyday(too bad the SP doesn't follow, but that will come in due time,we just need BTD approval).

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec